IL-17 Inhibition: A Valid Therapeutic Strategy in the Management of Hidradenitis Suppurativa

Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with a significant negative impact on the quality of life of patients. To date, the therapeutic landscape for the management of the disease has been extremely limited, resulting in a profound unmet need. Indeed, adalimumab, an anti...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Pharmaceutics Ročník 15; číslo 10; s. 2450
Hlavní autori:	Malvaso, Dalma, Calabrese, Laura, Chiricozzi, Andrea, Antonelli, Flaminia, Coscarella, Giulia, Rubegni, Pietro, Peris, Ketty
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	Basel MDPI AG 01.10.2023 MDPI
Predmet:	bimekizumab biologics brodalumab Chemokines Cytokines Disease Health aspects hidradenitis suppurativa IL-17 inhibitors Inflammation Localization Metabolic syndrome Monoclonal antibodies Neutrophils Pathogenesis Pathophysiology Psoriasis Review secukinumab Skin Skin diseases Tumor necrosis factor Tumor necrosis factor-TNF
ISSN:	1999-4923, 1999-4923
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!